GO:0044778 meiotic DNA integrity checkpoint signaling: Meiosis Surveillance Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0044778 meiotic DNA integrity checkpoint signaling is a biological process that monitors DNA structure during meiosis and controls cell cycle progression in response to DNA damage, defects in DNA structure, or replication problems.
• The checkpoint begins with detection of DNA damage or replication defects and ends with signal transduction that can delay or arrest meiotic progression.
• Key kinases include ATM/ATR orthologs and CHK1/RAD53, which coordinate DNA damage signaling with meiotic progression in organisms from yeast to mammals.
• In male germline, CHEK1 coordinates DNA damage signaling and meiotic progression, and its loss leads to meiotic defects.
• In budding yeast, the Rad53 checkpoint kinase signals double-strand breaks during meiosis, and checkpoint mechanisms directly and indirectly control initiation of meiotic recombination.
• Dysregulation of meiotic DNA integrity checkpoint signaling is linked to oocyte apoptosis, infertility, and developmental disorders such as ataxia-telangiectasia.
Description
Meiosis is a specialized cell division that produces haploid gametes, and its fidelity depends on the accurate repair of programmed DNA double-strand breaks (DSBs) and the proper coordination of recombination with cell cycle progression. The meiotic DNA integrity checkpoint signaling pathway (GO:0044778) is a surveillance mechanism that detects DNA damage, defects in DNA structure, or replication problems during meiosis and transduces signals to delay or arrest the meiotic cell cycle until repair is completed. This checkpoint is essential for preventing the transmission of mutations to offspring and for maintaining genomic stability in germ cells. Research over the past decades has identified conserved components of this checkpoint, including ATM/ATR kinases and their downstream effectors CHK1 and RAD53, which link DNA damage detection to cell cycle machinery. In fission yeast, the meiotic DNA replication checkpoint controls the onset of meiosis I in response to replication blocks. In budding yeast, the Rad53 checkpoint kinase is activated by meiotic DSBs and regulates recombination initiation. In mammals, CHEK1 is required for proper meiotic progression in the male germline, and its disruption leads to impaired spermatogenesis. Understanding meiotic DNA integrity checkpoint signaling is critical for reproductive biology, cancer research, and developmental disorders. Defects in this pathway can cause infertility, meiotic arrest, and aneuploidy, and may contribute to the pathogenesis of diseases such as ataxia-telangiectasia. This article provides a comprehensive overview of the ontology, mechanisms, key genes, disease relevance, and research methods for studying GO:0044778.
meiotic DNA integrity checkpoint signaling At A Glance
| GO ID | GO:0044778 |
|---|---|
| GO term | meiotic DNA integrity checkpoint signaling |
| Ontology | biological_process |
| Synonym | meiotic DNA integrity checkpoint |
| Major function | Monitors DNA integrity during meiosis and controls cell cycle progression in response to DNA damage or replication defects |
| Starts with | Detection of DNA damage, defects in DNA structure, or DNA replication problems |
| Ends with | Signal transduction that delays or arrests meiotic progression |
| Key kinases | ATM/ATR, CHK1, RAD53 |
| Organisms studied | Saccharomyces cerevisiae, Schizosaccharomyces pombe, mouse, human |
What Is GO:0044778?
GO:0044778 meiotic DNA integrity checkpoint signaling is defined as a signal transduction process that controls cell cycle progression in response to changes in DNA structure by monitoring the integrity of the DNA during meiosis. The checkpoint begins with detection of DNA damage, defects in DNA structure, or DNA replication problems, and ends with signal transduction that ultimately modulates the meiotic cell cycle. This process ensures that meiotic cells do not progress to the next stage until DNA lesions are repaired, thereby safeguarding the genome of gametes.
Why Is meiotic DNA integrity checkpoint signaling Important in Cell Biology?
Meiotic DNA integrity checkpoint signaling is essential for maintaining genomic stability during gametogenesis. It ensures that programmed DNA double-strand breaks are repaired before the cell commits to meiotic divisions, preventing the formation of aneuploid gametes and the transmission of mutations to the next generation. Defects in this checkpoint are associated with infertility, meiotic arrest, and developmental disorders, making it a critical area of research in reproductive biology and cancer.
• Prevents transmission of DNA damage to offspring by delaying meiosis until repair is complete.
• Coordinates meiotic recombination with cell cycle progression to ensure proper chromosome segregation.
• Required for male germline development; CHEK1 loss impairs meiotic progression in mice.
• Controls initiation of meiotic recombination in budding yeast through direct and indirect mechanisms.
• Dysregulation is linked to oocyte apoptosis and infertility.
• Mutations in checkpoint components are associated with ataxia-telangiectasia and cancer predisposition.
• Provides a model for understanding DNA damage response pathways conserved from yeast to humans.
• Potential target for reproductive medicine and cancer therapy.
• Helps explain mechanisms of aneuploidy and birth defects.
• Offers insights into meiosis-specific checkpoint adaptations.
What Happens During meiotic DNA integrity checkpoint signaling?
Detection of DNA damage and replication defects
In simple terms: The cell senses that something is wrong with its DNA during meiosis.
The meiotic DNA integrity checkpoint is activated by DNA double-strand breaks, other DNA lesions, or stalled replication forks that occur during meiotic prophase or pre-meiotic S phase. Sensor kinases such as ATM and ATR (or their yeast orthologs Tel1 and Mec1) recognize these abnormalities and initiate the checkpoint response. In fission yeast, the meiotic DNA replication checkpoint monitors replication completion and prevents entry into meiosis I when replication is blocked.
Signal transduction by checkpoint kinases
In simple terms: A molecular relay system transmits the alarm to the cell cycle machinery.
Following detection, sensor kinases activate downstream effector kinases, notably CHK1 in mammals and Rad53 in budding yeast. In budding yeast, Rad53 is activated in response to meiotic double-strand breaks and is required for signaling these breaks during the meiotic cell cycle. In mice, CHEK1 coordinates DNA damage signaling with meiotic progression in the male germline, and its depletion leads to meiotic defects. These kinases amplify the signal and phosphorylate multiple targets to execute the checkpoint response.
Cell cycle delay or arrest
In simple terms: The cell pauses its division cycle to allow time for DNA repair.
Activated checkpoint kinases ultimately inhibit cell cycle progression, typically by preventing entry into meiosis I or by delaying progression through meiotic prophase. In fission yeast, the meiotic DNA replication checkpoint delays the onset of meiosis I until replication is complete. In mammals, checkpoint activation can lead to oocyte apoptosis if damage is irreparable, as observed in ASH1L-deficient oocytes. This arrest provides a window for DNA repair and ensures that damaged DNA is not passed on.
Coordination with meiotic recombination
In simple terms: The checkpoint also fine-tunes the process that generates genetic diversity.
The checkpoint is not only a brake but also a regulator of meiotic recombination. In budding yeast, DNA damage checkpoint mechanisms directly and indirectly control the initiation of meiotic recombination. This ensures that recombination is properly timed and that sufficient DSBs are generated for faithful chromosome segregation. The interplay between checkpoint signaling and recombination is critical for meiotic success.
Key Genes Involved in GO:0044778 meiotic DNA integrity checkpoint signaling
The following genes and proteins are central to meiotic DNA integrity checkpoint signaling, as supported by experimental evidence in yeast, mouse, and human systems.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATM | Sensor kinase that detects DNA double-strand breaks and initiates checkpoint signaling | Mutations cause ataxia-telangiectasia; studied in meiosis and cancer |
| ATR | Sensor kinase responding to replication stress and DNA damage | Conserved checkpoint initiator; potential target in cancer |
| CHEK1 | Effector kinase coordinating DNA damage signaling with meiotic progression | Required for male germline meiosis; knockout causes meiotic defects |
| RAD53 | Budding yeast effector kinase signaling meiotic double-strand breaks | Key model for checkpoint signaling during meiosis |
| MEC1 | Budding yeast ATR ortholog; sensor kinase in meiotic checkpoint | Involved in meiotic recombination control |
| TEL1 | Budding yeast ATM ortholog; sensor kinase | Functions in meiotic DNA damage response |
| ASH1L | Histone methyltransferase regulating DNA damage response in oocytes | Knockout leads to oocyte apoptosis and infertility |
| H2AX | Histone variant phosphorylated at DNA damage sites | Marker of checkpoint activation; used in imaging studies |
| RAD51 | Recombinase involved in repair of meiotic DSBs | Downstream target of checkpoint; essential for recombination |
| DMC1 | Meiosis-specific recombinase | Required for interhomolog recombination; regulated by checkpoint |
| SPO11 | Topoisomerase-like enzyme generating meiotic DSBs | Initiates recombination; its activity is monitored by checkpoint |
| CDC25 | Phosphatase that promotes cell cycle progression | Inhibited by checkpoint kinases to enforce arrest |
| WEE1 | Kinase that inhibits CDK1 | Part of checkpoint-mediated cell cycle delay |
| CDK1 | Cyclin-dependent kinase driving meiotic divisions | Target of checkpoint regulation |
| BRCA1 | DNA repair protein involved in homologous recombination | Linked to checkpoint and meiotic recombination |
| BRCA2 | DNA repair protein facilitating RAD51 loading | Mutations cause cancer and meiotic defects |
| MDC1 | Mediator of DNA damage checkpoint | Amplifies ATM signaling |
| TP53 | Tumor suppressor mediating apoptosis in response to damage | May influence oocyte apoptosis in checkpoint failure |
How Is meiotic DNA integrity checkpoint signaling Regulated?
Meiotic DNA integrity checkpoint signaling is regulated at multiple levels. Sensor kinases ATM/ATR are activated by DNA damage and replication stress, and their activity is modulated by mediator proteins such as MDC1. Downstream effector kinases CHK1 and RAD53 are phosphorylated and activated by upstream kinases, and their activity is counteracted by phosphatases to allow checkpoint recovery once damage is repaired. In budding yeast, the checkpoint is intimately linked to meiotic recombination, with Rad53 activation depending on the formation of programmed DSBs. In mammals, CHEK1 activity is essential for coordinating meiotic progression, and its regulation may involve feedback from recombination intermediates. Additionally, epigenetic regulators such as ASH1L influence the DNA damage response in oocytes, indirectly affecting checkpoint outcomes.
meiotic DNA integrity checkpoint signaling and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATM | Ataxia-telangiectasia; cancer predisposition | ATM knockout mouse; patient-derived cells |
| CHEK1 | Male infertility; meiotic defects | Conditional Chek1 knockout mouse |
| ASH1L | Oocyte apoptosis; infertility | Ash1l knockout mouse |
| RAD53 | Meiotic recombination defects (yeast model) | Saccharomyces cerevisiae rad53 mutants |
| MEC1 | Replication checkpoint defects (yeast model) | S. cerevisiae mec1 mutants |
Ataxia-telangiectasia and DNA damage response disorders
Ataxia-telangiectasia is caused by mutations in ATM, a key sensor kinase in the meiotic DNA integrity checkpoint. Patients exhibit neurodegeneration, immunodeficiency, and cancer predisposition, highlighting the importance of this pathway in human health. Although the meiotic role of ATM is not fully understood, its function in DNA damage signaling is conserved and critical for genomic stability.
Infertility and meiotic arrest
Defects in meiotic DNA integrity checkpoint signaling can lead to meiotic arrest and infertility. In mice, loss of CHEK1 in the male germline impairs meiotic progression, resulting in defective spermatogenesis. Similarly, ASH1L deficiency in oocytes causes apoptosis due to unresolved DNA damage, contributing to infertility. These findings underscore the importance of checkpoint signaling for gamete production.
Cancer and genomic instability
Checkpoint kinases such as ATM, ATR, and CHK1 are frequently dysregulated in cancer. While their roles in mitosis are well established, their meiotic functions may also contribute to germ cell tumors and developmental cancers. Understanding meiotic checkpoint signaling could inform cancer therapies targeting DNA damage response pathways.
From meiotic DNA integrity checkpoint signaling-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate meiotic checkpoint activation? | Knockout cell line (e.g., HEK293T, mouse ES cells) followed by DNA damage treatment |
| What is the role of a specific phosphorylation site in checkpoint kinase? | Point mutation knock-in (e.g., kinase-dead or phospho-mutant) |
| How does a disease-associated mutation affect checkpoint function? | Knock-in of patient mutation in cell line or mouse |
| Where does the checkpoint protein localize during meiosis? | Tagged knock-in (e.g., GFP) in germ cells |
| Can overexpression of a checkpoint gene rescue meiotic defects? | Overexpression cell model or transgenic mouse |
| What genes are essential for meiotic checkpoint signaling? | CRISPR library screening in meiosis-competent cells |
How to Study the meiotic DNA integrity checkpoint signaling Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Loss-of-function phenotypes | Identify essential meiotic checkpoint genes |
| Phosphoproteomics | Kinase substrate phosphorylation | Map signaling networks downstream of ATM/ATR |
| Immunofluorescence | Protein localization and foci formation | Detect γH2AX, RAD51 foci in meiosis |
| Live-cell imaging | Real-time protein dynamics | Track Rad53 or CHK1 activation in yeast/mouse |
| RNA-seq | Transcriptional changes | Analyze gene expression in checkpoint mutants |
| Single-cell RNA-seq | Cell-to-cell variability | Study heterogeneity in meiotic progression |
| Yeast genetics | Genetic interactions and epistasis | Dissect checkpoint pathways in S. cerevisiae |
| Mouse models | In vivo meiotic phenotypes | Assess fertility and germ cell development |
Genetic screens and knockout models
CRISPR-Cas9 knockout screens are powerful for identifying genes required for meiotic DNA integrity checkpoint signaling. For example, knockout of Chek1 in mouse germ cells revealed its essential role in meiotic progression. Similarly, yeast deletion libraries have been used to uncover checkpoint components. These screens can be coupled with DNA damage agents to enrich for checkpoint-defective mutants.
Phosphoproteomics and signaling analysis
Mass spectrometry-based phosphoproteomics can identify substrates of checkpoint kinases such as ATM, ATR, CHK1, and RAD53 during meiosis. This approach has been used to map phosphorylation events in response to meiotic DSBs. Quantitative phosphoproteomics allows monitoring of checkpoint activation dynamics and crosstalk with recombination machinery.
Imaging and cytogenetics
Immunofluorescence microscopy of meiotic chromosome spreads can visualize checkpoint activation markers such as phosphorylated H2AX (γH2AX) and RAD51 foci. Live-cell imaging of tagged proteins (e.g., GFP-Rad53) in yeast meiosis provides spatiotemporal information on checkpoint signaling. These methods are essential for understanding the kinetics of checkpoint response.
Transcriptomics and single-cell analysis
RNA-seq and single-cell RNA-seq can reveal transcriptional changes associated with checkpoint activation or failure in germ cells. For instance, oocytes from Ash1l knockout mice show altered expression of DNA damage response genes. Single-cell approaches can dissect heterogeneity in meiotic progression and checkpoint engagement.
How CRISPR Can Be Used to Study GO:0044778 meiotic DNA integrity checkpoint signaling
Knockout
CRISPR knockout of checkpoint genes such as CHEK1, ATM, or ATR in cell lines or animal models can reveal their essential roles in meiotic DNA integrity checkpoint signaling. For example, conditional Chek1 knockout in mouse germ cells leads to meiotic defects and impaired spermatogenesis. Knockout models are invaluable for studying loss-of-function phenotypes and identifying downstream effectors.
Point Mutation
Point mutations can be introduced to dissect specific domains or phosphorylation sites of checkpoint kinases. For instance, kinase-dead mutants of CHK1 or RAD53 can be generated to separate kinase-dependent from scaffold functions. Such models help determine which activities are critical for meiotic checkpoint signaling.
Knock-in
Knock-in of disease-associated mutations or tagged versions of checkpoint proteins allows precise functional analysis. For example, knocking in a patient-derived ATM mutation can model ataxia-telangiectasia and assess its impact on meiosis. Tagged knock-ins (e.g., GFP) enable live-cell imaging of checkpoint proteins during meiosis.
Overexpression
Overexpression of checkpoint genes or their dominant-negative variants can perturb signaling and reveal gain-of-function phenotypes. Overexpressing a constitutively active CHK1 may cause meiotic arrest, while dominant-negative mutants can bypass checkpoint control. These models are useful for testing sufficiency and for identifying downstream targets.
How EDITGENE Supports meiotic DNA integrity checkpoint signaling Research
Researchers studying meiotic DNA integrity checkpoint signaling-related genes often need to determine whether a candidate gene is causally involved in the pathway, which requires precise genetic manipulation. EDITGENE provides a comprehensive suite of CRISPR-based services to support such investigations, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for meiotic DNA integrity checkpoint signaling research.
Frequently Asked Questions About meiotic DNA integrity checkpoint signaling
What is meiotic DNA integrity checkpoint signaling?
It is a biological process (GO:0044778) that monitors DNA integrity during meiosis and controls cell cycle progression in response to DNA damage or replication defects.
What genes are involved in meiotic DNA integrity checkpoint signaling?
Key genes include ATM, ATR, CHEK1, RAD53, MEC1, TEL1, and ASH1L, among others.
How does the meiotic DNA integrity checkpoint work?
Sensor kinases detect DNA damage, activate effector kinases like CHK1 or RAD53, and delay the meiotic cell cycle until repair is complete.
Why is the meiotic DNA integrity checkpoint important?
It prevents transmission of mutations to offspring and ensures proper chromosome segregation during gamete formation.
What diseases are associated with defects in meiotic DNA integrity checkpoint signaling?
Defects are linked to infertility, meiotic arrest, ataxia-telangiectasia, and cancer predisposition.
Which model organisms are used to study meiotic DNA integrity checkpoint signaling?
Saccharomyces cerevisiae, Schizosaccharomyces pombe, and mouse models are widely used.
What is the role of CHEK1 in meiosis?
CHEK1 coordinates DNA damage signaling with meiotic progression in the male germline, and its loss causes meiotic defects.
How is Rad53 involved in meiotic checkpoint signaling?
Rad53 is a budding yeast effector kinase that signals double-strand breaks during meiosis and regulates recombination initiation.
Can CRISPR be used to study meiotic DNA integrity checkpoint signaling?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect gene function in this pathway.
What methods are used to study meiotic DNA integrity checkpoint signaling?
Common methods include CRISPR screens, phosphoproteomics, immunofluorescence, live-cell imaging, and RNA-seq.
Conclusion
Meiotic DNA integrity checkpoint signaling (GO:0044778) is a conserved surveillance pathway that safeguards the genome during gametogenesis by detecting DNA damage and coordinating cell cycle progression with repair. Its components, from ATM/ATR sensors to CHK1/RAD53 effectors, are critical for fertility and genomic stability, and their dysfunction is linked to infertility and cancer. Continued research using advanced CRISPR models and multi-omics approaches will further illuminate the mechanisms and therapeutic potential of this pathway.
References
- 1. Chaudhary MW et al.. 2014. Ataxia-telangiectasia: future prospects.. Appl Clin Genet 7:159-67 PMID: 25258552
- 2. Abe H et al.. 2018. CHEK1 coordinates DNA damage signaling and meiotic progression in the male germline of mice.. Hum Mol Genet 27(7):1136-1149 PMID: 29360988
- 3. Murakami H et al.. 1999. Meiotic DNA replication checkpoint control in fission yeast.. Genes Dev 13(19):2581-93 PMID: 10521402
- 5. Longhese MP et al.. 2006. The cellular response to chromosome breakage.. Mol Microbiol 60(5):1099-108 PMID: 16689788
- 6. Argunhan B et al.. 2013. Direct and indirect control of the initiation of meiotic recombination by DNA damage checkpoint mechanisms in budding yeast.. PLoS One 8(6):e65875 PMID: 23762445
- 7. Cartagena-Lirola H et al.. 2008. Role of the Saccharomyces cerevisiae Rad53 checkpoint kinase in signaling double-strand breaks during the meiotic cell cycle.. Mol Cell Biol 28(14):4480-93 PMID: 18505828
- 8. Zhang T et al.. 2022. ASH1L contributes to oocyte apoptosis by regulating DNA damage.. Am J Physiol Cell Physiol 323(4):C1264-C1273 PMID: 36094439
